North America

Thu
10
Oct

European legal cannabis a "prime investment target" for North American money

European cannabis has become a “prime investment target for excess cash” for North American firms emboldened by high valuations in USA, a sector expert says.

Ben Langley, chief executive of investment company Grow Biotech, said that a “steady wave of capital flowing to Europe” is starting to roll across the Atlantic from entrepreneurs and investors who have “cash to deploy, global ambitions, and experience operating in ‘legal’ markets”.

According to broker Liberum, cannabis sector fundraising in UK has only reached £45mln year-to-date, “a drop in the ocean” compared to the £30bn raised in North America.

Wed
09
Oct

Legalisation of medical and other cannabis has little effect on crime

A new study funded by a grant from the National Institute of Justice sought to determine the effect of the change in legal status of cannabis on crimes rates.

Eleven states and the District of Columbia have legalised cannabis. The study, which looked at legalisation and sales of recreational or broad medical purposes cannabis in Colorado and Washington, found minimal to no effect on rates of violent and property crimes in those states.

Wed
09
Oct

2 cannabis stocks that could land a game-changing partner in 2020

Last year, nearly every cannabis company was racing to find a big-time partner. Cronos Group, for example, secured a $1.8 billion deal with tobacco giant Altria Group. Cronos stock ran more than 100% on the news, rising to a peak market cap of $20 billion. Canopy Growth, meanwhile, locked down a $4 billion capital infusion from Constellation Brands, causing shares to skyrocket.

Wed
09
Oct

Using cannabis to relieve carpal tunnel syndrome

Certain people in the cannabis business are more prone to carpal tunnel syndrome than others who work in the industry. Just like professions that require their workers to type, cook, or use a cash register all day, marijuana trimmers suffer due to the detailed, repetitive nature of their work.

The carpal tunnel is a thin tube in your wrist, pretty much from elbow to palm of the hand, that houses the median nerve, which becomes inflamed when the syndrome kicks in. Fortunately, cannabis is here to save the day yet again.

Wed
09
Oct

What is the functionality of CBD in skincare products?

The demand for topical cannabis products has risen in the U.S., especially products that contain only cannabidiol (CBD). But what, exactly, does it do for skincare?

Wed
09
Oct

The budding industry of cannabis tech

From food and drink to health and wellness and beyond, there’s one plant we can’t seem to get enough of: cannabis. It seems like every consumer product nowadays is taking part in reefer madness.

Wed
09
Oct

'There’s no playbook': Two failed pot deals highlight growing pains

If cannabis investors were waiting for a sign that the beleaguered industry is turning the corner, Tuesday wasn’t that day.

Pot stocks came under pressure after U.S. cannabis operator MedMen Enterprises Inc. announced the termination of its all-stock takeover of PharmaCann LLC. The sector’s growing pains were also evident in Canada, as Aleafia Health Inc. ended a five-year supply agreement with Aphria Inc., citing a failure to meet obligations under the deal.

Wed
09
Oct

Understanding how to evaluate water-soluble technology

Lately, there has been much discussion about water-soluble technology in the cannabis industry. Many companies, eager to convey a transformative milestone to the public, are announcing that they’ve developed their own water-soluble technology. Unfortunately for consumers, many of these claims are premature.

The technology being claimed is, in the vast majority of cases, a nanoemulsion. Put simply, a nanoemulsion is created when an oil is combined with functional ingredients and then blasted with energy, causing the oil particles to split into smaller pieces. When the particles are made small enough, it looks like they dissolve in water (they become “water compatible”). 

Tue
08
Oct

Legalizing cannabis is the answer to vaping concerns

Over the past few months the media has been awash with reports of people getting sick from vaping. Nearly every day, news outlets report on otherwise healthy, usually young, people who have fallen critically ill from the use of vapes that they believed to be a safer alternative to smoking. In response, politicians have been taking action to get ahead of the problem, with most relying on some form of vape ban. A handful of governors and President Trump have proposed banning all flavored vape cartridges, while Massachusetts Gov.

Tue
08
Oct

Marijuana can be effective in treating pain and insomnia: Study

Cannabis can treat both pain and insomnia in people who want to avoid prescription and sleep medications, a study has found.

The study, published in the Journal of Psychoactive Drugs, looked at 1,000 people taking legalised marijuana in an American state.Researchers in the US found that among the 65 per cent of people taking cannabis for pain, 80 per cent found it was very or extremely helpful.

Eighty-two per cent of these people were able to reduce, or stop taking over the counter pain medications and 88 per cent were able to stop taking opioid painkillers.

The study suggested that cannabis could lower opioid use. However, the researchers noted that more needs to be done to understand the potential therapeutic benefits of cannabis.

Pages

Subscribe to RSS - North America